In late 2024, an avian H5N1 influenza virus derived from clade 2.3.4.4b was isolated from a severe human infection in British Columbia (A/British Columbia/PHL-2032/2024), revealing a rare combination of substitutions E190D and Q226H as minor variants in the receptor-binding site (RBS). We recombinantly produced hemagglutinins (HA) harboring these mutations and conducted receptor-binding and structural analyses. The wild-type HA with hallmark residues E190 and Q226 retained strong binding to α2-3 N-linked glycans, whereas E190D and Q226H abolished binding to α2-3 N- and O-linked glycans and no switch to α2-6 sialosides. The bulkier H226 caused steric clashes within the RBS, whereas E190D eliminated a conserved hydrogen bond with Sia-1, disrupting receptor engagement. Although D190 and H226 in this isolate are deleterious to engagement with known glycan receptors and not compatible with human-to-human transmission, continued surveillance is essential to monitor any changes in key RBS residues in circulating H5N1 viruses.